News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Daily News Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes Shelley Wood July 19, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020
News Daily News LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR Yael L. Maxwell March 01, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017